The government data from Jan Aushadhi medicine stores, offering affordable medicines, showed that over 33 percent of the total sale has come from diabetes and cardiovascular disease.
In last one year, diabetes constituted 17.31 percent, and 16.42 percent of the total sale of generic drugs came from cardiovascular diseases,” Ravi Dadhich, chief executive officer, Pharmaceuticals and Medical Devices Bureau of India (PMBI), said.
In the generic medical outlets opened across the country under Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana (PMBJP), Dadhich said Telmisartan, Amlodipine and Metformin were among the top-selling drugs.
“The drug Telmisartan (sold at Rs 12 for 10 tablets/unit) has witnessed an average sale of over 9.3 lakh units per month. Similarly, Amlodipine (sold at Rs 5.50 for 10 tablets/unit) and Metformin Hydrochloride 500 mg (extended release) (sold at Rs 17.60 for 10 tablets/unit) were seeing an average sale of 8 lakh units per month in the generic stores,” he added.